Chart: Biotech Stocks - Change in Cash-On-Hand
-
Font Size:
-
Print
- TweetThis
Rob Zenilman submits: Over the last two fiscal quarters, the change (increase/decrease) in cash & short term investments for companies in the Biotech sector ranged from 627.5% (BMRN) down to -24.0% (PHRM), with a median value of -3.4%
Data in table version -- click on a ticker for opinion and analysis of the company:
| Most | Cash | Cash | |||
|---|---|---|---|---|---|
| Recent FQ | Recent | Previous | |||
| Ticker | Company | Ending | FQ ($mm) | FQ ($mm) | Change% |
| AFFX | Affymetrix Inc. | 03/31/06 | $254.3 | $284.9 | -10.8%
|
| ALXN | Alexion Pharmaceutic | 03/31/06 | $189.3 | $230.5 | -17.9%
|
| AMGN | Amgen Inc. | 03/31/06 | $5,047.0 | $5,255.0 | -4.0%
|
| AMLN | Amylin Pharmaceutica | 03/31/06 | $386.4 | $443.4 | -12.9%
|
| BIIB | Biogen Idec Inc. | 03/31/06 | $849.4 | $850.8 | -0.2%
|
| BMRN | BioMarin Pharmaceuti | 03/31/06 | $347.7 | $47.8 | 627.5%
|
| BSTE | Biosite Incorporated | 03/31/06 | $131.2 | $132.4 | -0.9%
|
| CELG | Celgene Corporation | 03/31/06 | $772.6 | $724.3 | 6.7%
|
| DNA | Genentech Inc. | 03/31/06 | $2,284.0 | $2,365.2 | -3.4%
|
| ELN | Elan Corp. plc | 03/31/06 | $1,090.2 | $1,090.7 | 0.0%
|
| GILD | Gilead Sciences Inc. | 03/31/06 | $2,539.6 | $2,323.9 | 9.3%
|
| GPRO | Gen-Probe Inc. | 03/31/06 | $243.1 | $220.3 | 10.3%
|
| IMCL | Imclone Systems Inc. | 03/31/06 | $990.7 | $756.4 | 31.0%
|
| INCY | Incyte Corp. | 03/31/06 | $321.5 | $345.0 | -6.8%
|
| ISTA | ISTA Pharmaceuticals | 03/31/06 | $29.8 | $38.6 | -22.8%
|
| KOSP | KOS Pharmaceuticals | 03/31/06 | $437.8 | $412.7 | 6.1%
|
| MEDI | MedImmune Inc. | 03/31/06 | $854.1 | $610.5 | 39.9%
|
| NABI | Nabi Biopharmaceutic | 04/01/06 | $81.6 | $106.9 | -23.7%
|
| NBIX | Neurocrine Bioscienc | 03/31/06 | $264.5 | $273.1 | -3.1%
|
| ONXX | Onyx Pharmaceuticals | 03/31/06 | $258.3 | $274.8 | -6.0%
|
| PGNX | Progenics Pharmaceut | 03/31/06 | $160.4 | $166.1 | -3.4%
|
| PHRM | Pharmion Corp. | 03/31/06 | $185.1 | $243.4 | -24.0%
|
| TELK | Telik Inc. | 03/31/06 | $185.3 | $203.8 | -9.1%
|
| VRTX | Vertex Pharmaceutica | 03/31/06 | $339.5 | $361.2 | -6.0% |
Data: CapitalIQ
Related:
- Most recent opinion and analysis of Biotech stocks
- Full transcripts of recent conference calls in the Biotech sector
- Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?
Related Articles
|


























